Emerald Mutual Fund Advisers Trust’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.69M | Buy |
768,972
+160,759
| +26% | +$1.82M | 0.53% | 72 |
|
|
2025
Q1 | $7.02M | Buy |
608,213
+58,525
| +11% | +$675K | 0.5% | 78 |
|
|
2024
Q4 | $4.66M | Sell |
549,688
-101,292
| -16% | -$858K | 0.28% | 98 |
|
|
2024
Q3 | $7.54M | Buy |
650,980
+121,615
| +23% | +$1.41M | 0.39% | 84 |
|
|
2024
Q2 | $6.24M | Hold |
529,365
| – | – | 0.33% | 94 |
|
|
2024
Q1 | $6.28M | Buy |
+529,365
| New | +$6.28M | 0.33% | 99 |
|
|
2021
Q4 | – | Sell |
-136,554
| Closed | -$2.38M | – | 226 |
|
|
2021
Q3 | $2.38M | Sell |
136,554
-269,658
| -66% | -$4.71M | 0.08% | 158 |
|
|
2021
Q2 | $9.73M | Sell |
406,212
-10,000
| -2% | -$240K | 0.32% | 107 |
|
|
2021
Q1 | $10.7M | Buy |
+416,212
| New | +$10.7M | 0.35% | 106 |
|